• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Drug Safety and Risk Management Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

Current Number of Vacancies = 1
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

 


Chair
 

Almut Winterstein, Ph.D.
Expertise: Pharmacoepidemiology
Term: 02/10/2011-05/31/2014
Professor and Graduate Program Director
Pharmaceutical Outcomes & Policy
College of Pharmacy
Epidemiology, College of Public Health and Health Professions and College of Medicine
University of Florida
PO Box 100496
Gainesville, Florida 32610 

Designated Federal Official
Kristina A. Toliver, PharmD
Division of Advisory Committee and Consultant Management
Office of Executive Programs
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
Phone: (301) 796-9001
Fax: (301) 847-8533
E-mail: DSaRM@fda.hhs.gov

**Patrizia Cavazzoni, M.D.
Expertise: Industry Representative
Term: 4/28/2012-10/31/2015
Senior Vice President - Worldwide Safety Strategy
Pfizer, Inc
235 E 42nd St.
Mailstop 219/9/1
New York, New York 10017

William Cooper, M.D.
Expertise: Epidemiology, Pediatrics
Term: 02/10/2011-05/31/2013
Professor of Pediatrics and Preventive Medicine
Suite 313 Oxford House
1313 21st Avenue South
Nashville, Tennessee 37232

Brian Erstad, Pharm.D.
Expertise: Patient Safety and Outcomes
Term: 06/01/2011 - 05/31/2015
Professor
University of Arizona College of Pharmacy
Department of Pharmacy Practice & Science
1703 East Mabel Street
Tucson, Arizona 85721

Sonia Hernandez-Diaz, M.D., Dr.PH
Expertise: Epidemiology, Pharmacoepidemiology
Term: 02/10/2011-05/31/2014
Associate Professor
Department of Epidemiology
Harvard School of Public Health
677 Huntington Avenue
Boston, Massachusetts 02115

*Karen M. Hopkins, M.D.
Expertise: Neurodevelopmental Disabilities, Pediatrics
Term: 10/11/2012 - 05/31/2016
Clinical Associate Professor of Pediatrics
New York University School of Medicine
Division of Developmental Behavioral Pediatrics
530 First Avenue, Suite 3A
New York, New York 10016

Peter Kaboli, M.D.
Expertise: Internal Medicine
Term: 02/10/2011-05/31/2014
Associate Professor, Department of Internal Medicine
University of Iowa Carver College of Medicine
Iowa City Veterans Administration Medical Center
Highway 6 West
Iowa City, Iowa 52240

David Madigan, Ph.D.
Expertise: Statistics
Term: 02/10/2011-05/31/2014
Professor, Chair, Department of Statistics
Columbia University
Room 1005 SSW, MC 4690
1255 Amsterdam Avenue
New York, New York 10027

Elaine H. Morrato, Dr.PH.
Expertise: Risk Communication/Epidemiology
Term: 06/29/2009 - 5/31/2013
Associate Professor
Department of Health Systems, Management and Policy
University of Colorado, Anschutz Medical Campus
Colorado School of Public Health
13001 East 17th Place
Aurora, CO 80045

Jeanmarie Perrone, M.D. FACMT
Expertise: Emergency Medicine/Toxicology
Term: 10/11/2012 – 05/31/2016
Associate Professor, Emergency Medicine
Director, Division of Medical Toxicology
Department of Emergency Medicine
Perelman School of Medicine at the University of Pennsylvania
3400 Spruce Street
Philadelphia, Pennsylvania 19107

Marjorie Shaw Phillips, MS, R.Ph., FASHP
Expertise: Medication Safety
Term: 10/11/2012-05/31/2016
Pharmacy Coordinator, Clinical Research and Education
Georgia Health Sciences Health System
Clinical Professor of Pharmacy Practice
University of Georgia College of Pharmacy
1120 15th Street, BI-2101
Augusta, Georgia 30912

Maria Suarez-Almazor, M.D., Ph.D.
Expertise: Epidemiology
Term: 02/10/2011-05/31/2014
Barnts Family Distinguished Professor
University of Texas MD Anderson Cancer Center
1515 Holcombe Boulevard (Unit 1465)
Houston, Texas 77030

T. Mark Woods, Pharm.D.
Expertise: Therapeutics, Pharmacy
Term: 02/10/2011-05/31/2013
Clinical Coordinator and Residency Program Director
Pharmacy Department
Saint Luke’s Hospital
4401 Wornall Road
Kansas City, Missouri 64111

** Industry Representative, non voting
* Consumer Representative (voting)

-
-